Paper335035
Plasmodium falciparum in culture: use of outdated erthrocytes and description of the candle jar method.
Jensen JB and 1 other. J Parasitol, 1977. Cited by 390 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Plasmodium falciparum in culture: use of outdated erthrocytes and description of the candle jar method. Papers, record 335035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/335035
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasmodium falciparum in culture: use of outdated erthrocytes and description of the candle jar method.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythrocytes | Major topic |
| Plasmodium falciparum | Major topic |
| Animals | |
| Cell Division | |
| Cells, Cultured | |
| Culture Media | |
| Erythrocyte Aging | |
| Humans |
Source PubMed
Cited by103
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 390 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,763,926 | Design, Synthesis, and Evaluation of New 1,4-Naphthoquinone-1,2,3-triazoles as Antimalarial Agents. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42763926 | PubMed |
| 41,559,880 | Erythrocyte Membrane Protein 3 (EMAP3) Is Exposed on the Surface of the Plasmodium berghei Infected Red Blood Cell. | Mol Microbiol | 2026 | https://conductscience.org/library/papers/41559880 | PubMed |
| 41,063,078 | Antimalarial potential of Matricaria chamomilla-derived MgO nanoparticles against Plasmodium falciparum strains: an experimental study. | BMC Complement Med Ther | 2025 | https://conductscience.org/library/papers/41063078 | PubMed |
| 40,668,067 | Tafenoquine Disrupts Intraerythrocytic Stages of Malaria Parasites by Inhibiting Nonclassical Pathways of β-Hematin Nucleation and Growth. | Biochemistry | 2025 | https://conductscience.org/library/papers/40668067 | PubMed |
| 39,298,535 | Understanding the significance of oxygen tension on the biology of Plasmodium falciparum blood stages: From the human body to the laboratory. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39298535 | PubMed |
| 39,206,510 | In vitro evaluation of ganaplacide/lumefantrine combination against Plasmodium falciparum in a context of artemisinin resistance. | J Antimicrob Chemother | 2024 | https://conductscience.org/library/papers/39206510 | PubMed |
| 38,289,473 | Identifying Fast and Slow-Acting Antimalarial Compounds of Pandemic Response Box Against Blood-Stage Culture of Plasmodium falciparum 3D7. | Curr Microbiol | 2024 | https://conductscience.org/library/papers/38289473 | PubMed |
| 38,178,227 | In vitro delayed response to dihydroartemisinin of malaria parasites infecting sickle cell erythocytes. | Malar J | 2024 | https://conductscience.org/library/papers/38178227 | PubMed |
| 37,513,747 | Cultivation of Asexual Intraerythrocytic Stages of Plasmodium falciparum. | Pathogens | 2023 | https://conductscience.org/library/papers/37513747 | PubMed |
| 37,500,754 | Nonclassical mechanisms to irreversibly suppress β-hematin crystal growth. | Commun Biol | 2023 | https://conductscience.org/library/papers/37500754 | PubMed |
| 36,466,013 | Cytotoxicity and Anti-Plasmodium berghei Activity of Emodin Loaded Nanoemulsion. | Iran J Parasitol | 2022 | https://conductscience.org/library/papers/36466013 | PubMed |
| 35,718,642 | Toxoplasma metabolic flexibility in different growth conditions. | Trends Parasitol | 2022 | https://conductscience.org/library/papers/35718642 | PubMed |
| 35,308,105 | Structure of the Pf12 and Pf41 heterodimeric complex of Plasmodium falciparum 6-cysteine proteins. | FEMS Microbes | 2022 | https://conductscience.org/library/papers/35308105 | PubMed |
| 35,168,649 | Development and optimizing a simple and cost-effective medium for in vitro culture of Plasmodium berghei-ANKA strain with conserving its infectivity in BALB/c mice. | BMC Res Notes | 2022 | https://conductscience.org/library/papers/35168649 | PubMed |
| 34,943,772 | A Mitochondria-Penetrating Peptide Exerts Potent Anti-Plasmodium Activity and Localizes at Parasites' Mitochondria. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34943772 | PubMed |
| 34,557,241 | Interaction between Chitosan and Chloroquine against Plasmodium berghei and P. falciparum Using In-Vivo and In-Vitro Tests. | Iran J Parasitol | 2021 | https://conductscience.org/library/papers/34557241 | PubMed |
| 32,268,910 | The response of Plasmodium falciparum to isoleucine withdrawal is dependent on the stage of progression through the intraerythrocytic cell cycle. | Malar J | 2020 | https://conductscience.org/library/papers/32268910 | PubMed |
| 31,472,356 | Activity of methylgerambullin from Glycosmis species (Rutaceae) against Entamoeba histolytica and Giardia duodenalis in vitro. | Int J Parasitol Drugs Drug Resist | 2019 | https://conductscience.org/library/papers/31472356 | PubMed |
| 29,211,247 | Immunoproteomics of Plasmodium falciparum-infected red blood cell membrane fractions. | Mem Inst Oswaldo Cruz | 2017 | https://conductscience.org/library/papers/29211247 | PubMed |
| 28,615,843 | In vitro adaptability of Plasmodium falciparum to different fresh serum alternatives. | J Parasit Dis | 2017 | https://conductscience.org/library/papers/28615843 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/335035
GET https://conductscience.org/api/papers/v1/335035/cited_by?page=2